MX2009013063A - Formulacion farmaceutica para la produccion de tabletas de desintegracion rapida. - Google Patents
Formulacion farmaceutica para la produccion de tabletas de desintegracion rapida.Info
- Publication number
- MX2009013063A MX2009013063A MX2009013063A MX2009013063A MX2009013063A MX 2009013063 A MX2009013063 A MX 2009013063A MX 2009013063 A MX2009013063 A MX 2009013063A MX 2009013063 A MX2009013063 A MX 2009013063A MX 2009013063 A MX2009013063 A MX 2009013063A
- Authority
- MX
- Mexico
- Prior art keywords
- weight
- pharmaceutical formulation
- production
- disintegrating tablets
- rapidly disintegrating
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Abstract
La invención se refiere a una formulación farmacéutica en forma de aglomerados, que contiene A) un adyuvante que consiste de a) 60-97% en peso de azúcar o alcoholes de azúcar, b) 1-25% en peso de un agente de desintegración, c) 1-15% en peso de polímeros formadores de película, insolubles en agua, d) 0-15% en peso de polímeros solubles en agua, y e) 0-15% en peso de adyuvantes farmacéuticos convencionales adicionales, la suma de los componentes a) hasta e) forman un total de 100% en peso, y B) por lo menos un ingrediente activo.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP07109722 | 2007-06-06 | ||
PCT/EP2008/056805 WO2008148742A2 (de) | 2007-06-06 | 2008-06-03 | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2009013063A true MX2009013063A (es) | 2010-01-15 |
Family
ID=39643971
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2009013063A MX2009013063A (es) | 2007-06-06 | 2008-06-03 | Formulacion farmaceutica para la produccion de tabletas de desintegracion rapida. |
Country Status (11)
Country | Link |
---|---|
US (1) | US10406105B2 (es) |
EP (1) | EP2164462B1 (es) |
JP (2) | JP5627455B2 (es) |
KR (2) | KR101903781B1 (es) |
CN (1) | CN101707930B (es) |
AU (1) | AU2008258627A1 (es) |
BR (1) | BRPI0812064B8 (es) |
CA (1) | CA2686964A1 (es) |
ES (1) | ES2639130T3 (es) |
MX (1) | MX2009013063A (es) |
WO (1) | WO2008148742A2 (es) |
Families Citing this family (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
AUPS088702A0 (en) * | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
UA95093C2 (uk) | 2005-12-07 | 2011-07-11 | Нікомед Фарма Ас | Спосіб одержання кальцієвмісної сполуки |
WO2008148731A1 (de) * | 2007-06-06 | 2008-12-11 | Basf Se | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
CA2686964A1 (en) | 2007-06-06 | 2008-12-11 | Basf Se | Pharmaceutical formulation for the production of rapidly disintegrating tablets |
CN102988318A (zh) * | 2008-11-25 | 2013-03-27 | 田边三菱制药株式会社 | 口腔速崩片及其制备方法 |
AR074689A1 (es) * | 2008-12-19 | 2011-02-02 | Solvay Pharm Bv | Formulaciones farmaceuticas de desintegracion rapida pre-compactadas de compuestos con baja biodisponibilidad oral. proceso de preparacion |
TWI455733B (zh) * | 2009-03-30 | 2014-10-11 | Toray Industries | 口腔內崩壞性被覆錠劑 |
JPWO2010119851A1 (ja) * | 2009-04-14 | 2012-10-22 | ライオン株式会社 | 口腔内崩壊錠 |
JP6073543B2 (ja) * | 2010-07-08 | 2017-02-01 | 沢井製薬株式会社 | ロラタジン含有口腔内崩壊錠の製造方法 |
JP2013537531A (ja) | 2010-08-04 | 2013-10-03 | トーマス・ジュリアス・ボロディ | 糞便細菌叢移植のための組成物ならびにそれを作製および使用する方法ならびにそれを送達するためのデバイス |
CN110200954A (zh) | 2010-12-13 | 2019-09-06 | 萨利克斯药品有限公司 | 胃和结肠的配制剂及其制备和使用方法 |
JP6521564B2 (ja) * | 2010-12-22 | 2019-05-29 | ビーエーエスエフ ソシエタス・ヨーロピアBasf Se | 速崩性の固体被覆剤形 |
US8715729B2 (en) * | 2010-12-22 | 2014-05-06 | Basf Se | Rapidly disintegrating, solid coated dosage form |
AU2012225305B2 (en) | 2011-03-09 | 2017-06-08 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
JP6245786B2 (ja) * | 2011-10-17 | 2017-12-13 | 大同化成工業株式会社 | 医薬用結合剤及び該結合剤を用いた製剤 |
WO2013176774A1 (en) | 2012-05-25 | 2013-11-28 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
WO2013181694A1 (en) | 2012-06-04 | 2013-12-12 | Gaurav Agrawal | Compositions and methods for treating crohn's disease and related conditions and infections |
BR112015001640A2 (pt) | 2012-07-27 | 2017-07-04 | Redhill Biopharma Ltd | formulações e métodos de produção de formulações para uso em evacuação colônica |
KR102114487B1 (ko) | 2012-09-20 | 2020-05-22 | 주식회사 다이셀 | 산형(酸型) 카르복시 메틸 셀룰로오스 및 결정 셀룰로오스를 포함하는 붕해성 입자 조성물 및 그 조성물을 포함하는 구강내 붕해 정제 |
ITMI20121628A1 (it) * | 2012-09-28 | 2014-03-29 | Pharmafilm Srl | Film orodisperdibili autosupportanti a rapida dissoluzione per uso terapeutico o alimentare |
EP2991649B1 (en) | 2013-04-30 | 2020-06-03 | Thomas Julius Borody | Compositions for treating obsessive-compulsive disorder |
JP6476122B2 (ja) * | 2013-09-27 | 2019-02-27 | 株式会社ダイセル | 二段階の湿式造粒工程で製造される崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤 |
AU2015251692B2 (en) | 2014-04-21 | 2019-12-19 | Daicel Corporation | Disintegrating particle composition including microfibrous cellulose |
JP6718866B2 (ja) * | 2014-10-16 | 2020-07-08 | カーギル インコーポレイテッド | 直接圧縮性のエリスリトールの調製方法及びその使用 |
KR102561989B1 (ko) | 2015-05-14 | 2023-07-31 | 핀치 테라퓨틱스 홀딩스 엘엘씨 | 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치 |
CN108243608A (zh) | 2015-05-22 | 2018-07-03 | 亚利桑那大学董事会 | 用于治疗自闭症谱系障碍及相关症状的方法 |
US11214773B2 (en) | 2015-09-24 | 2022-01-04 | San Diego State University (Sdsu) Foundation | Antibacterial and protective bacteriophage formulations and methods for making and using them |
US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
US11213549B2 (en) | 2016-10-11 | 2022-01-04 | Finch Therapeutics Holdings Llc | Compositions and method for treating primary sclerosing cholangitis and related disorders |
US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
US11026978B2 (en) | 2016-10-11 | 2021-06-08 | Finch Therapeutics Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
EP3606541A1 (en) | 2017-04-05 | 2020-02-12 | Crestovo Holdings LLC | Compositions and methods for treating parkinson's disease (pd) and related disorders |
US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
CA3064773A1 (en) | 2017-05-26 | 2018-11-29 | Crestovo Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
CN111328284A (zh) | 2017-08-07 | 2020-06-23 | 芬奇治疗公司 | 用于维持和恢复健康的肠道屏障的组合物和方法 |
US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
AU2019351017A1 (en) | 2018-09-27 | 2021-04-29 | Finch Therapeutics Holdings Llc. | Compositions and methods for treating epilepsy and related disorders |
AU2020258631B2 (en) * | 2019-04-17 | 2023-11-02 | Nordiccan A/S | Fast disintegrating cannabinoid tablets |
US11633351B2 (en) * | 2019-12-13 | 2023-04-25 | Nordiccan A/S | Fast disintegrating cannabinoid tablets |
US11179331B1 (en) * | 2020-04-21 | 2021-11-23 | Cure Pharmaceutcai Holding Corp | Oral soluble film containing sildenafil citrate |
Family Cites Families (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3434138A1 (de) | 1984-09-18 | 1986-03-27 | Basf Ag, 6700 Ludwigshafen | Verfahren zur herstellung von unloeslichen, nur wenig quellbaren pulverfoermigen polymerisaten |
US5569469A (en) * | 1984-10-16 | 1996-10-29 | Vectorpharma International, S.P.A. | Poorly soluble medicaments supported on polymer substances in a form suitable for increasing their dissolving rate |
GB8518301D0 (en) * | 1985-07-19 | 1985-08-29 | Fujisawa Pharmaceutical Co | Hydrodynamically explosive systems |
IL115445A (en) * | 1994-10-17 | 1999-08-17 | Akzo Nobel Nv | Solid pharmaceutical compositions comprising low dosage active ingredient oil and excipient capable of binding water and their preparation |
US5879342A (en) * | 1996-10-21 | 1999-03-09 | Kelley; Gregory S. | Flexible and reinforced tubing |
EP0839526A3 (en) | 1996-10-31 | 1999-01-07 | Takeda Chemical Industries, Ltd. | Solid pharmaceutical preparation with fast buccal disintegration or dissolution |
US6274727B1 (en) | 1996-11-15 | 2001-08-14 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Method for producing shaped and unshaped polyol masses |
DE19709663A1 (de) * | 1997-03-10 | 1998-09-17 | Basf Ag | Verwendung von redispergierbaren Polymerpulvern oder Polymergranulaten als Bindemittel zur Herstellung von festen pharmazeutischen Darreichungsformen |
US5874418A (en) * | 1997-05-05 | 1999-02-23 | Cydex, Inc. | Sulfoalkyl ether cyclodextrin based solid pharmaceutical formulations and their use |
FR2781152B1 (fr) * | 1998-07-20 | 2001-07-06 | Permatec Tech Ag | Utilisation d'un polymere de type acrylique en tant qu'agent de desagregation |
JP3404648B2 (ja) * | 1998-07-28 | 2003-05-12 | 武田薬品工業株式会社 | 速崩壊性固形製剤 |
DE19912031A1 (de) * | 1999-03-17 | 2000-09-21 | Basf Ag | Verwendung von quervernetztem Polyvinylpyrrolidon zur Erhöhung der Zerfallgeschwindigkeit von kompakten teilchenförmigen Wasch- und Reinigungsmitteln |
US20020071864A1 (en) | 1999-03-25 | 2002-06-13 | Yuhan Corporation | Rapidly disintegrable tablet for oral administration |
US6495177B1 (en) * | 1999-08-13 | 2002-12-17 | Warner Chilcott Laboratories Ireland Limited | Orally dissolvable nutritional supplement |
DE10011137A1 (de) * | 2000-03-10 | 2001-09-13 | Basf Ag | Verfahren zur Einstellung der Teilchengröße von Popcornpolymeren während der Popcornpolymerisation |
US20020147232A1 (en) * | 2000-05-26 | 2002-10-10 | Claus Sundgreen | Pharmaceutical compositions comprising desglymidodrine as an active drug substance |
UA80393C2 (uk) * | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
CA2430829C (en) * | 2000-12-07 | 2010-06-22 | Altana Pharma Ag | Rapidly disintegrating tablet comprising an acid-labile active ingredient |
US20020127277A1 (en) * | 2000-12-22 | 2002-09-12 | Yihong Qiu | Solid dosage forms of divalproex sodium |
CN1703203A (zh) * | 2001-09-26 | 2005-11-30 | 法玛西雅公司 | 感官可接受的口腔内崩解组合物 |
GB0124953D0 (en) | 2001-10-17 | 2001-12-05 | Novartis Ag | Organic Compounds |
FR2831820B1 (fr) * | 2001-11-05 | 2004-08-20 | Ethypharm Sa | Comprime orodispersible presentant une grande homogeneite et son procede de preparation |
US6723348B2 (en) * | 2001-11-16 | 2004-04-20 | Ethypharm | Orodispersible tablets containing fexofenadine |
US7118765B2 (en) | 2001-12-17 | 2006-10-10 | Spi Pharma, Inc. | Co-processed carbohydrate system as a quick-dissolve matrix for solid dosage forms |
US20060270618A1 (en) | 2001-12-18 | 2006-11-30 | Dorian Bevec | Novel pharmaceutical composition of interferon gamma or pirfenidone with molecular diagnostics for the improved treatment of interstitial lung diseases |
UA76325C2 (uk) * | 2002-02-26 | 2006-07-17 | Астразенека Аб | Лікарський препарат іресси, який містить водорозчинне похідне целюлози (варіанти), та спосіб його одержання |
GB0204771D0 (en) * | 2002-02-28 | 2002-04-17 | Phoqus Ltd | Fast disintegrating tablets |
JP2004026521A (ja) | 2002-06-21 | 2004-01-29 | Mitsubishi Chemicals Corp | フラーレンの製造設備及びフラーレンの製造方法 |
AU2003291457A1 (en) * | 2002-11-08 | 2004-06-03 | Glaxo Group Limited | Pharmaceutical antiviral compositions |
WO2004073687A1 (en) * | 2003-02-19 | 2004-09-02 | H. Lundbeck A/S | Method for preparation of an agglomerate using melt agglomeration |
JP2004265216A (ja) | 2003-03-03 | 2004-09-24 | Seiko Epson Corp | 印刷装置、受信装置、中継装置、印刷システムおよび印刷方法 |
US8545881B2 (en) | 2004-04-19 | 2013-10-01 | Eurand Pharmaceuticals, Ltd. | Orally disintegrating tablets and methods of manufacture |
US20050244492A1 (en) * | 2004-04-30 | 2005-11-03 | Mehra Dev K | Rapidly disintegrating tablets comprising titanium dioxide |
US20050244343A1 (en) * | 2004-04-30 | 2005-11-03 | Withiam Michael C | Oral care products comprising silica |
JP2006076971A (ja) * | 2004-09-13 | 2006-03-23 | Basf Ag | 口腔内崩壊錠 |
JP4446177B2 (ja) * | 2005-01-21 | 2010-04-07 | 東和薬品株式会社 | 耐湿性口腔内崩壊錠の製造方法 |
JP5394746B2 (ja) | 2005-12-21 | 2014-01-22 | ビーエーエスエフ ソシエタス・ヨーロピア | 錠剤崩壊剤としての微粒子状架橋ポリビニルピロリドン |
DE202006020168U1 (de) * | 2005-12-21 | 2008-07-17 | Basf Se | Pharmazeutische Formulierung für die Herstellung von schnell zerfallenden Tabletten |
WO2008148731A1 (de) | 2007-06-06 | 2008-12-11 | Basf Se | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
CN101686931B (zh) | 2007-06-06 | 2013-06-19 | 巴斯夫欧洲公司 | 用于制备可咀嚼片剂和锭剂的药物配制剂 |
EP2170273B1 (de) | 2007-06-06 | 2014-11-26 | Basf Se | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten |
CA2686964A1 (en) | 2007-06-06 | 2008-12-11 | Basf Se | Pharmaceutical formulation for the production of rapidly disintegrating tablets |
DE102008038678B4 (de) * | 2008-08-12 | 2012-03-08 | Continental Automotive Gmbh | Verfahren und Vorrichtung zum Schätzen einer Emission mindestens einer Abgaskomponente |
-
2008
- 2008-06-03 CA CA002686964A patent/CA2686964A1/en not_active Abandoned
- 2008-06-03 US US12/663,046 patent/US10406105B2/en active Active
- 2008-06-03 KR KR1020107000103A patent/KR101903781B1/ko active IP Right Grant
- 2008-06-03 KR KR1020167017268A patent/KR20160083132A/ko not_active Application Discontinuation
- 2008-06-03 EP EP08760389.0A patent/EP2164462B1/de active Active
- 2008-06-03 WO PCT/EP2008/056805 patent/WO2008148742A2/de active Application Filing
- 2008-06-03 JP JP2010510759A patent/JP5627455B2/ja active Active
- 2008-06-03 CN CN2008800188988A patent/CN101707930B/zh active Active
- 2008-06-03 ES ES08760389.0T patent/ES2639130T3/es active Active
- 2008-06-03 AU AU2008258627A patent/AU2008258627A1/en not_active Abandoned
- 2008-06-03 BR BRPI0812064A patent/BRPI0812064B8/pt active IP Right Grant
- 2008-06-03 MX MX2009013063A patent/MX2009013063A/es not_active Application Discontinuation
-
2014
- 2014-02-21 JP JP2014031168A patent/JP2014114322A/ja not_active Ceased
Also Published As
Publication number | Publication date |
---|---|
WO2008148742A2 (de) | 2008-12-11 |
ES2639130T3 (es) | 2017-10-25 |
WO2008148742A3 (de) | 2009-08-13 |
EP2164462B1 (de) | 2017-05-31 |
JP2014114322A (ja) | 2014-06-26 |
BRPI0812064B8 (pt) | 2021-05-25 |
JP2010529074A (ja) | 2010-08-26 |
BRPI0812064A2 (pt) | 2014-11-25 |
US10406105B2 (en) | 2019-09-10 |
US20100178349A1 (en) | 2010-07-15 |
CN101707930B (zh) | 2013-10-30 |
EP2164462A2 (de) | 2010-03-24 |
BRPI0812064B1 (pt) | 2019-08-13 |
AU2008258627A1 (en) | 2008-12-11 |
JP5627455B2 (ja) | 2014-11-19 |
CA2686964A1 (en) | 2008-12-11 |
CN101707930A (zh) | 2010-05-12 |
KR101903781B1 (ko) | 2018-11-13 |
KR20100028624A (ko) | 2010-03-12 |
KR20160083132A (ko) | 2016-07-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2009013063A (es) | Formulacion farmaceutica para la produccion de tabletas de desintegracion rapida. | |
WO2007071581A3 (de) | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten | |
WO2008148733A3 (de) | Pharmazeutische formulierung für die herstellung von schnell zerfallenden tabletten | |
WO2009043844A3 (en) | Orodispersible tablets | |
WO2006044421A3 (en) | Cardiac safe, rapid medication delivery | |
MX2009004439A (es) | Composicion de ibuprofeno. | |
WO2010066749A3 (en) | Ulipristal acetate tablets | |
TNSN08173A1 (en) | Dispersible tablets comprising deferasirox | |
WO2011147026A3 (en) | A stable pharmaceutical formulation comprising telmisartan and hydrochlorothiazide | |
WO2007008752A3 (en) | Sustained release pharmaceutical compositions for highly water soluble drugs | |
FI2508188T3 (fi) | Dapagliflotsiinipropyleeniglykolihydraattia sisältäviä farmaseuttisia formulaatioita | |
AU2010308458A8 (en) | Orally transformable tablets | |
WO2009006095A3 (en) | Dual portion lozenge dosage form | |
TW200603841A (en) | Dispersible tablets comprising a benzoic acid derivative | |
WO2012001074A3 (en) | Pharmaceutical compositions comprising 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one lactate monohydrate | |
WO2008023016A3 (en) | Galenic formulations of aliskiren | |
WO2006115770A3 (en) | Orally disintegrating pharmaceutical tablet formulations of olanzapine | |
WO2007134158A3 (en) | Granules comprising calcium carbonate, a binder and a porosity increasing agent, processes of manufacturing, use in therapy | |
WO2006053089A3 (en) | Methods and formulations for making pharmaceutical compositions containing bupropion | |
SI1773292T1 (sl) | Hitro razgradljiva oralno disperzibilna farmacevtska oblika | |
WO2009109289A3 (de) | Gemisch zur herstellung von schnell zerfallenden tabletten | |
WO2005115346A3 (en) | Pharmaceutical composition containing risperidone | |
WO2005120518A3 (en) | Use of atp analogues for treatment of cardiovascular diseases | |
IL179177A (en) | A pharmaceutical product including acyclovir and delivery compound, dosage unit, use of acyclovir in the preparation of the pharmaceutical product, use of the pharmaceutical product in the preparation of a drug and a method for the preparation of the pharmaceutical product | |
TW200640472A (en) | Solid pharmaceutical composition comprising telithromycin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |